mTOR-inhibitors may aggravate chronic hepatitis E

2014

Journal of Hepatology , Volume 61 - Issue 4 p. 746- 754

Additional Metadata
Keywords	Everolimus, Hepatitis E virus, PI3K-PKB-mTOR pathway, Rapamycin
Persistent URL	dx.doi.org/10.1016/j.jhep.2014.07.016, hdl.handle.net/1765/85304
Journal	Journal of Hepatology
Grant	This work was funded by the European Commission 7th Framework Programme; grant id fp7/260644 - Small-molecule Inhibitor Leads Versus emerging and neglected RNA viruses (SILVER)
Organisation	Department of Gastroenterology & Hepatology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Zhou, X, Wang, Y, Metselaar, H.J, Janssen, H.L.A, Peppelenbosch, M.P, & Pan, Q. (2014). mTOR-inhibitors may aggravate chronic hepatitis E. Journal of Hepatology, 61(4), 746–754. doi:10.1016/j.jhep.2014.07.016

See Also
article PI3K-Akt-mTOR axis sustains rotavirus infection via the 4E-BP1 mediated autophagy pathway and represents an antiviral target Y. Yin (Yuebang), W. Dang (Wen), X. Zhou (Xinying), L. Xu (Lei), W. Wang (Wenshi), W. Cao (Wanlu), Chen, S. (Sunrui), J. Su (Junhong), Cai, X. (Xuepeng), Xiao, S. (Shaobo), et al. Q. Pan (Qiuwei)

Publication